Contact us via E-Mail
Follow us on LinkedInAll-time Popular Posts
A biobetter trastuzumab is on the way 
EGA president calls on Member States to boost market access for biosimilars in the EU 
3rd Forum on Biosimilars 
Pfizer starts biosimilar rituximab Phase I/II trial 
Indian Biosimilars Market 
World’s first biosimilar antibody* is approved in Korea 
A biosimilar manufacturer: Celltrion 
2 patents down, 1 to expire: Herceptin biosimilar coming to EU
Post Tagged with: "FDA"
August 3, 2017 6:42 AM
Amgen and Allergan submit biosimilar Biologics License Application for ABP 980 to US FDA
August 1, 2017 8:26 AM
Celltrion and Teva announce U.S. FDA acceptance of BLA for proposed biosimilar to Herceptin (trastuzumab)
July 25, 2017 12:13 PM
Merck announces launch of Renflexis (Remicade biosimilar) in the United States
July 24, 2017 7:14 AM
Merck receives tentative approval for LUSDUNA Nexvue (insulin glargine injection) from FDA
July 16, 2017 2:59 PM
FDA Oncologic Drugs Advisory Committee unanimously recommends approval of Mylan and Biocon’s proposed biosimilar trastuzumab
